-
1دورية أكاديمية
المؤلفون: Motzer R., Alekseev B., Rha S. -Y., Porta C., Eto M., Powles T., Grunwald V., Hutson T. E., Kopyltsov E., Mendez-Vidal M. J., Kozlov V., Alyasova A., Hong S. -H., Kapoor A., Gordoa T. A., Merchan J. R., Winquist E., Maroto P., Goh J. C., Kim M., Gurney H., Patel V., Peer A., Procopio G., Takagi T., Melichar B., Rolland F., de Giorgi U., Wong S., Bedke J., Schmidinger M., Dutcus C. E., Smith A. D., Dutta L., Mody K., Perini R. F., Xing D., Choueiri T. K., Boccardo F.
المساهمون: Motzer, R., Alekseev, B., Rha, S. -Y., Porta, C., Eto, M., Powles, T., Grunwald, V., Hutson, T. E., Kopyltsov, E., Mendez-Vidal, M. J., Kozlov, V., Alyasova, A., Hong, S. -H., Kapoor, A., Gordoa, T. A., Merchan, J. R., Winquist, E., Maroto, P., Goh, J. C., Kim, M., Gurney, H., Patel, V., Peer, A., Procopio, G., Takagi, T., Melichar, B., Rolland, F., de Giorgi, U., Wong, S., Bedke, J., Schmidinger, M., Dutcus, C. E., Smith, A. D., Dutta, L., Mody, K., Perini, R. F., Xing, D., Choueiri, T. K., Boccardo, F.
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Renal Cell, Everolimu, Female, Human, Kidney Neoplasm, Male, Middle Aged, Phenylurea Compound, Programmed Cell Death 1 Receptor, Progression-Free Survival, Protein Kinase Inhibitor, Quinoline, Sunitinib, Survival Analysis
وصف الملف: ELETTRONICO
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33616314; info:eu-repo/semantics/altIdentifier/wos/WOS:000637799800007; volume:384; firstpage:1289; lastpage:1300; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11567/1046356Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103105017
-
2دورية أكاديمية
المؤلفون: Powles T., van der Heijden M. S., Castellano D., Galsky M. D., Loriot Y., Petrylak D. P., Ogawa O., Park S. H., Lee J. -L., De Giorgi U., Bogemann M., Bamias A., Eigl B. J., Gurney H., Mukherjee S. D., Fradet Y., Skoneczna I., Tsiatas M., Novikov A., Suarez C., Fay A. P., Duran I., Necchi A., Wildsmith S., He P., Angra N., Gupta A. K., Levin W., Bellmunt J., Lee J. L., Westgeest H., Flechon A., Ou Y. -C., Park I., Matveev V., Perez-Valderrama B., Cheng S., Frank S., Anido U., Hamzaj A., Retz M., Sridhar S., Scagliotti G. V., Voortman J., Alekseev B., Alyasova A., Komyakov B., Dumez H., Pavic M., Kimura G., Mizokami A., Osanto S., Arranz J. A., Piersma D., Shin S. J., Karyakin O., Delgado I., Gonzalez J. L., Pang S. -T., Tran A., Lipatov O., Su W. -P., Flaig T., Alva A., Park Kyong H., Kopyltsov E., Almagro E., Domenech M., Chang Y. -H., Sautois B., Ravaux A., Aravantinos G., Georgoulias V., Mulder S., Kim Y. J., Kater F., Chevreau C., Tagawa S., Zalewski P., Joly F., Hatiboglu G., Gianni L., Morelli F., Tambaro R., Hashimoto Y., Nosov A., Font A., Rodriguez-Vida A. M., Jones R., Vasudev N., Srinivas S., Zhang J., Gil T., Finch D., Grimm M. -O., Su Y. -L., Chowdhury S., Hocking C., Plas E., North S., Jensen N. V., Theodore C., Imkamp F., Peer A., Kobayashi T., Sakai H., Sassa N., Yoshimura K., Aarts M., Ferreira Castro A., Topuzov M., Rodriguez J. F., Vazquez F. J., Tsai Y. -C., Crabb S., Hussain S., Bendell J., Gross-Goupil M., Gwenaelle G., Berger R., Statsenko G., Evans L., Drakaki A., Somer B., Davis I., Lynam J., Borges G., Dettino A., Martins G., Zucca L. E., Agerbaek M., Kalofonos H., Rosenbaum E., Enokida H., Kikukawa H., Nishimura K., Tamada S., Uemura M., Lopez Y., Gietema J., Slojewski M., Fernandes I., Smolin A., Mazhar D., Kalebasty A. R., Carthon B., Loidl W., Franke F., Girotto G., Alimohamed N., Macfarlane R., Pappot H., Niegisch G., Mavroudis D., Sella A., Porta C., Ebara S., Nakamura M., Obara W., Okuno N., Shinohara N., Sugimoto M., Suzuki A., Tokuda N., Uemura H., Yamaguchi A., Ramirez F., Rozanowski P., Wiechno P., Keam B., Kislov N., Plaksin D., Cicin I., Kumar S., Rosales J., Vaishampayan U., Culine S., Papandreou C., Nara T., Erman M., Kreiger L., Janoski J., Rosa D., Siqueira M., Canil C., Sengelov L., Tourani J. -M., Arai G., Hashine K., Kawakita M., Nakaigawa N., Nomi H., Shiina H., Suzuki H., Yonese J., Kuri R., Macedo E., Rivera S., Villalobos Prieto A., Polakiewicz-Gilowska A., Zaucha R., Lopes F., Ponomarev R., Pomerantz M., Shariat S., Luk C., Lesniewski-Kmak K.
المساهمون: Powles, T., van der Heijden, M. S., Castellano, D., Galsky, M. D., Loriot, Y., Petrylak, D. P., Ogawa, O., Park, S. H., Lee, J. -L., De Giorgi, U., Bogemann, M., Bamias, A., Eigl, B. J., Gurney, H., Mukherjee, S. D., Fradet, Y., Skoneczna, I., Tsiatas, M., Novikov, A., Suarez, C., Fay, A. P., Duran, I., Necchi, A., Wildsmith, S., He, P., Angra, N., Gupta, A. K., Levin, W., Bellmunt, J., Lee, J. L., Westgeest, H., Flechon, A., Ou, Y. -C., Park, I., Matveev, V., Perez-Valderrama, B., Cheng, S., Frank, S., Anido, U., Hamzaj, A., Retz, M., Sridhar, S., Scagliotti, G. V., Voortman, J., Alekseev, B., Alyasova, A., Komyakov, B., Dumez, H., Pavic, M., Kimura, G., Mizokami, A., Osanto, S., Arranz, J. A., Piersma, D., Shin, S. J., Karyakin, O., Delgado, I., Gonzalez, J. L., Pang, S. -T., Tran, A., Lipatov, O., Su, W. -P., Flaig, T., Alva, A., Park Kyong, H., Kopyltsov, E., Almagro, E., Domenech, M., Chang, Y. -H., Sautois, B., Ravaux, A., Aravantinos, G., Georgoulias, V., Mulder, S., Kim, Y. J., Kater, F., Chevreau, C., Tagawa, S., Zalewski, P., Joly, F., Hatiboglu, G., Gianni, L., Morelli, F., Tambaro, R., Hashimoto, Y., Nosov, A., Font, A., Rodriguez-Vida, A. M., Jones, R., Vasudev, N., Srinivas, S., Zhang, J., Gil, T., Finch, D., Grimm, M. -O., Su, Y. -L.
مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Female, Human, Immune Checkpoint Inhibitor, Male, Middle Aged, Time Factor, Treatment Outcome, Urologic Neoplasm, Urothelium
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32971005; info:eu-repo/semantics/altIdentifier/wos/WOS:000599899200041; volume:21; issue:12; firstpage:1574; lastpage:1588; numberofpages:15; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11586/389577Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85091519786
الإتاحة: https://doi.org/10.1016/S1470-2045Test(20)30541-6
http://hdl.handle.net/11586/389577Test -
3
المؤلفون: Motzer, R, Alekseev, B, Rha, SY, Porta, C, Eto, M, Powles, T, Grunwald, V, Hutson, TE, Kopyltsov, E, Mendez-Vidal, MJ, Kozlov, V, Alyasova, A, Hong, SH, Kapoor, A, Gordoa, TA, Merchan, JR, Winquist, E, Maroto, P, Goh, JC, Kim, M, Gurney, H, Patel, V, Peer, A, Procopio, G, Takagi, T, Melichar, B, Rolland, F, De Giorgi, U, Wong, S, Bedke, J, Schmidinger, M, Dutcus, CE, Smith, AD, Dutta, L, Mody, K, Perini, RF, Xing, DY, Choueiri, TK, CLEAR Trial Investigators
المصدر: NEW ENGLAND JOURNAL OF MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instnameمصطلحات موضوعية: Oncology, Male, Programmed Cell Death 1 Receptor, Medizin, Pembrolizumab, 030204 cardiovascular system & hematology, urologic and male genital diseases, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Sunitinib, Medicine, 030212 general & internal medicine, Humanized, Aged, 80 and over, General Medicine, Middle Aged, female genital diseases and pregnancy complications, Kidney Neoplasms, Progression-Free Survival, Quinolines, Female, Lenvatinib, medicine.drug, Adult, medicine.medical_specialty, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Antibodies, 03 medical and health sciences, Internal medicine, Carcinoma, Humans, Progression-free survival, Everolimus, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, business.industry, Phenylurea Compounds, Renal Cell, medicine.disease, Survival Analysis, chemistry, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0334f0faf7037f77f5c4cb15439bd9c2Test
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4803Test
